Amgen says the company plans to open a new technology and innovation site in Hyderabad, India. The site, known as Amgen India, will be developed to accelerate digital capabilities across the global organization to further advance Amgen’s pipeline of medicines, according to the company.
Amgen India will be located in Hitec City, a suburb of Hyderabad, occupying six floors of the RMZ Spire Tower 110. The city of Hyderabad, located in the state of Telangana, was selected for its world-class talent across medicine, life and data sciences, and the rapidly advancing field of artificial intelligence, explained David M. Reese, MD, executive vice president and CTO at Amgen. The site can accommodate up to 3,000 people and will be operational in Q4 2024, he added.
“At a time when a quickly aging global population needs more innovation, the convergence of biotechnology and technology is enabling Amgen to work with greater speed, confidence, and efficiency, an incredibly exciting milestone for which we have been preparing for over a decade,” said Reese. “Amgen has been a leader in biotechnology for over 40 years and establishing this new site in India, a country known for its world-class technology and life sciences talent, marks a significant step forward in our journey to deliver on our mission to serve patients.”
Amgen India will initially build and accelerate new technology solutions and digital capabilities at scale that will enhance efficiencies across the enterprise, he continued, adding that the site will offer roles that strengthen key areas of Amgen’s business, including AI, data science, life science and other additional global capabilities over time.
To lead Amgen’s expanded presence in India, Som Chattopadhyay has been appointed national executive for India.
Images are for reference only.Images and contents gathered automatic from google or 3rd party sources.All rights on the images and contents are with their legal original owners.
Comments are closed, but trackbacks and pingbacks are open.